APPLICATION
ANDA070699
TYPE
ANDA
ORIGINAL APPROVAL
1987-06-15
LATEST ACTION
1998-08-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
METHYLDOPATE HYDROCHLORIDEDiscontinued
METHYLDOPATE HYDROCHLORIDE 50MG/ML · INJECTABLE · INJECTION
Approval history
1998-08-14Labeling · Supplement 10AP
1997-07-22Labeling · Supplement 7AP
1997-01-07Manufacturing (CMC) · Supplement 8AP
1996-10-22Manufacturing (CMC) · Supplement 6AP
1995-01-11Labeling · Supplement 5AP
1993-12-22Manufacturing (CMC) · Supplement 4AP
1992-06-08Labeling · Supplement 3AP
1991-09-10Labeling · Supplement 2AP
1988-06-30Labeling · Supplement 1AP
1987-06-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.